🧬Notice of Closed Meeting by National Human Genome Research Institute
The Department of Health and Human Services announces a closed meeting for the National Human Genome Research Institute's Special Emphasis Panel to evaluate grant applications. The meeting, scheduled for April 22, 2025, will focus on confidential discussions relating to genomic community resources and trade secrets.
Learn More🧬FDA Guidance on Heritable Genomic Alterations in Animals
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry #187B entitled "Heritable Intentional Genomic Alterations in Animals: The Approval Process." This guidance clarifies FDA's requirements and recommendations for developers of intentional genomic alterations (IGAs) in animals. The guidance is one of two companion documents. "Heritable Intentional Genomic Alterations in Animals: The Approval Process" describes how the FDA approval process applies to heritable IGAs in animals. The companion final guidance, GFI #187A entitled "Heritable Intentional Genomic Alterations in Animals: Risk-Based Approach," describes FDA's risk-based regulatory approach to the oversight of heritable IGAs in animals.
Learn More